Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients. (Q45992738)
Jump to navigation
Jump to search
scientific article published on 19 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients. |
scientific article published on 19 May 2009 |
Statements
1 reference
Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients. (English)
1 reference
T Heise
1 reference
E U Graefe-Mody
1 reference
S Hüttner
1 reference
A Ring
1 reference
D Trommeshauser
1 reference
K A Dugi
1 reference
19 May 2009
1 reference
1 reference
11
1 reference
786-794
1 reference
8
1 reference